Randomized Trial of Sodium-glucose Cotransporter 2 Inhibition in Heart Transplant Recipients
Latest Information Update: 09 Oct 2024
At a glance
- Drugs Empagliflozin (Primary)
- Indications Kidney disorders
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2024 New trial record